Lung Cancer Researchers Identify Gene Set That Shows Which Patients Benefit from Chemotherapy After Surgery

Lung cancer researchers have identified a genetic signature that can help doctors determine which patients with early-stage non-small cell lung cancer are at high risk for developing disease recurrence and therefore may benefit from chemotherapy after surgery ("adjuvant chemotherapy").

Walk to fight lung cancer in Roxbury

ROXBURY TWP. –Jim Dennison, a six-year lung cancer survivor, is organizing the inaugural “Free To Breathe” 3.5K walk at Horseshoe Lake in Succasunna on Saturday, Sept. 25.

Micro-RNA determines malignancy of lung cancer

A small RNA molecule determines whether or not lung cancer cells grow invasively and metastasize. This has been discovered in the culture dish by scientists of the German Cancer Research Center and the University Medical Center Mannheim. Moreover, they found out that the following is true also for patients with non-small cell lung cancer: The less micro-RNA is produced by tumor cells, the higher ...

Complex Lung Cancer Treatments Delivered Successfully at Leading Varian-Equipped Proton Therapy Center

Clinicians at the Rinecker Proton Therapy Center in Munich are reporting using advanced proton therapy systems supplied by Varian Medical Systems for difficult lung cancer treatments.

2nd Annual Cancer Targets And Therapeutics Conference, Oct 20-22, San Francisco, CA

Dr. Patrick Baeuerle, Vice President of Micromet, to present as a featured speaker at GTCbio's 2nd Annual Cancer Targets and Therapeutics Conference, part of the 6th Modern Drug Discovery and Development Summit on Oct. 20-22, 2010 in San Francisco, CA. Dr. Baeuerle will give a presentation on "BiTE Antibody-Engaged T-Cells for Cancer Therapy." MT110 is a novel BiTE antibody recognizing the pan ...